Abstract
Computer-aided detection (CADe) of masses in digital breast tomosynthesis (DBT) is crucial for early breast cancer diagnosis. However, the variability in the size and morphology of breast masses and their resemblance to surrounding tissues present significant challenges. Current CNN-based CADe methods, particularly those that use Feature Pyramid Networks (FPN), often fail to integrate multi-scale information effectively and struggle to handle dense glandular tissue with high-density or iso-density mass lesions due to the unidirectional integration and progressive attenuation of features, leading to high false positive rates. Additionally, the commonly indistinct boundaries of breast masses introduce uncertainty in boundary localization, which makes traditional Dirac boundary modeling insufficient for precise boundary regression. To address these issues, we propose the CU-Net network, which efficiently fuses multi-scale features and accurately models blurred boundaries. Specifically, the CU-Net introduces the Cross-Attention Adaptive Feature Pyramid Network (CA-FPN), which enhances the effectiveness and accuracy of feature interactions through a cross-attention mechanism to capture global correlations across multi-scale feature maps. Simultaneously, the Breast Density Perceptual Module (BDPM) incorporates breast density information to weight intermediate features, thereby improving the network's focus on dense breast regions susceptible to false positives. For blurred mass boundaries, we introduce Uncertainty Boundary Modeling (UBM) to model the positional distribution function of predicted bounding boxes for masses with uncertain boundaries. In comparative experiments on an in-house clinical DBT dataset and the BCS-DBT dataset, the proposed method achieved sensitivities of 89.68% and 72.73% at 2 false positives per DBT volume (FPs/DBT), respectively, significantly outperforming existing state-of-the-art detection methods. This method offers clinicians rapid, accurate, and objective diagnostic assistance, demonstrating substantial potential for clinical application.